Skip to main content

Table 3 COX proportional hazard regression analysis of follow-up information for 63 NSCLC patients

From: Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer

   

95.0% CI for Exp (B)

P

Exp(B)

Lower

Upper

Stage

0.006

1.813

1.186

2.772

Smoking

0.843

0.895

0.299

2.680

Gender

0.745

0.820

0.248

2.709

Age

0.517

0.985

0.941

1.031

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us